NCT07568561 Maternal Methyl-Nutrient Status and Infant Neurodevelopment Study
| NCT ID | NCT07568561 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Far Eastern Memorial Hospital |
| Condition | Infant Neurodevelopment |
| Study Type | OBSERVATIONAL |
| Enrollment | 240 participants |
| Start Date | 2026-05-27 |
| Primary Completion | 2029-01-18 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 240 participants in total. It began in 2026-05-27 with a primary completion date of 2029-01-18.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This prospective cohort study examines the relationship between maternal methyl-nutrient status during pregnancy and offspring neurodevelopment. It integrates maternal dietary, biomarker, genetic, and microbiome data and follows children up to 24 months.
Eligibility Criteria
Inclusion Criteria for Pregnant Women * Aged 20-45 years * Singleton pregnancy * Receiving routine prenatal care at the study site and planning to deliver at Far Eastern Memorial Hospital Exclusion Criteria for Pregnant Women * Diagnosed with major chronic diseases, including renal disease (defined as chronic kidney disease stage 3 or above or history of renal transplantation), liver disease (defined as liver cirrhosis or history of liver transplantation), or malignancy * Alcohol consumption during pregnancy * Diagnosed with eating disorders or psychiatric conditions that may impair the assessment of nutritional status Inclusion Criteria for Newborns ● Newborns delivered by mothers who participate in this study Exclusion Criteria for Newborns * Diagnosed with congenital anomalies, epilepsy, or severe brain injury * Inability to complete neurodevelopmental assessments at 6 months, 1 year, and 2 years of age at the study site * Infants whose mothers are diagnosed with eating disorders or psychiatric conditions that may impair the assessment of nutritional status
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07568561 clinical trial?
This trial is open to participants of all sexes, aged 0 Days or older, up to 45 Years, studying Infant Neurodevelopment. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07568561 currently recruiting?
Yes, NCT07568561 is actively recruiting participants. Contact the research team at carmentoe@hotmail.com for enrollment information.
Where is the NCT07568561 trial being conducted?
This trial is being conducted at New Taipei City, Taiwan, New Taipei City, Taiwan.
Who is sponsoring the NCT07568561 clinical trial?
NCT07568561 is sponsored by Far Eastern Memorial Hospital. The trial plans to enroll 240 participants.